Clinical Trials Directory

Trials / Completed

CompletedNCT03227965

Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cancer is a well known complication about long term transplantation. Cancer outcomes are due to the immunosuppressive treatment that prevents transplanted people from rejection. By lowering the effectiveness of the immune system, immune cells are no longer able to seek and destroy cancer cells. The goal here is to study immunes cells population of people that were transplanted 10 years ago and are now treated either by a corticosteroid - azathioprine association, or only by cyclosporine A.

Conditions

Interventions

TypeNameDescription
BIOLOGICALImmune cells population assesmentT lymphocytes population description through blood, urine and faeces samples

Timeline

Start date
2017-01-13
Primary completion
2018-05-15
Completion
2019-02-07
First posted
2017-07-24
Last updated
2019-04-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03227965. Inclusion in this directory is not an endorsement.

Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation (NCT03227965) · Clinical Trials Directory